Web Analytics

3 Latest Announced Rounds

  • $6,000,000
    Series A

    5 Investors

    Technology, Information and Internet
    May 31st, 2024
  • $22,000,000
    Series A

    2 Investors

    Biotechnology Research
    May 31st, 2024
  • $2,330,000
    Pre-Seed

    4 Investors

    Internet Marketplace Platforms
    May 31st, 2024
$829.76M Raised in 76 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Lux Capital

investor
United States - New York, NY
  • 16/11/2022
  • Series E
  • $90,000,000

Lux Capital is a venture capital firm that makes long-term bets on contrarians and outsiders. We believe the next generation of industrialist titans will be scientists, technologists and inventors who are doing more than challenging the status quo—they’re literally challenging the laws of physics. We have offices in New York City and Menlo Park.

Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built a $4 billion AUM firm of more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.

We invest in seed- and early-stage ventures across multiple sectors, including: 3D printing; machine learning; artificial intelligence; flying robots; surgical robots; synthetic biology; genomics; satellites; space; drones; computational imaging and recognition; new materials; holograms; “fixers” for the future; the internet of things; connected hardware; the smart home and virtual reality.


Related People

Peter HebertInvestor

Peter Hebert United States - Menlo Park, California,

Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. His goal: to seek out founders developing things most people thought would not work, yet if they did, would become so intrinsic to our way of life that we would someday take them for granted.

Today Lux supports a wide range of once-impossible-sounding advancements, including 3D printing and imaging, nuclear waste cleanup, machine learning and robots that fly or conduct microsurgery.

Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson for up to $6 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Everspin Technologies (NASDAQ: MRAM), Lux Research (acquired by Bregal Sagemount), Luxtera (acquired by Cisco for $660 million), SiBEAM (acquired by Silicon Image), Transphorm and Vium (acquired by Recursion). Current investments include Avail, Bright Machines, Flex Logix, Lux Health Tech Acquisition Corp. (NASDAQ: LUXAU), Matterport and Ripcord. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm.

Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.